Crosswalk between DSM-IV dependence and DSM-5 substance use disorders for opioids, cannabis, cocaine and alcohol

Ascertaining agreement between DSM-IV and DSM-5 is important to determine the applicability of treatments for DSM-IV conditions to persons diagnosed according to the proposed DSM-5.

Gespeichert in:

Autor*in:	Compton, Wilson M. [verfasserIn] Dawson, Deborah A. Goldstein, Risë B. Grant, Bridget F.

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	2013

Schlagwörter:	Substance use disorder DSM-IV DSM-5 Kappa Concordance Diagnosis

Umfang:	4

Übergeordnetes Werk:	Enthalten in: Statistical analysis to identify biomarkers for safety - Clark, Matthew ELSEVIER, 2018, an international journal on biomedical and psychosocial approaches, Amsterdam [u.a.]
Übergeordnetes Werk:	volume:132 ; year:2013 ; number:1 ; day:1 ; month:09 ; pages:387-390 ; extent:4

Links:	Volltext

DOI / URN:	10.1016/j.drugalcdep.2013.02.036

Katalog-ID:	ELV016911024

Internformat


LEADER	01000caa a22002652 4500
001	ELV016911024
003	DE-627
005	20230623132325.0
007	cr uuu---uuuuu
008	180602s2013 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.1016/j.drugalcdep.2013.02.036 \|2 doi
028	5	2	\|a GBVA2013012000002.pica
035			\|a (DE-627)ELV016911024
035			\|a (ELSEVIER)S0376-8716(13)00107-5
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
082	0		\|a 610
082	0	4	\|a 610 \|q DE-600
082	0	4	\|a 610 \|q VZ
084			\|a 15,3 \|2 ssgn
084			\|a PHARM \|q DE-84 \|2 fid
084			\|a 44.38 \|2 bkl
084			\|a 44.39 \|2 bkl
100	1		\|a Compton, Wilson M. \|e verfasserin \|4 aut
245	1	0	\|a Crosswalk between DSM-IV dependence and DSM-5 substance use disorders for opioids, cannabis, cocaine and alcohol
264		1	\|c 2013
300			\|a 4
336			\|a nicht spezifiziert \|b zzz \|2 rdacontent
337			\|a nicht spezifiziert \|b z \|2 rdamedia
338			\|a nicht spezifiziert \|b zu \|2 rdacarrier
520			\|a Ascertaining agreement between DSM-IV and DSM-5 is important to determine the applicability of treatments for DSM-IV conditions to persons diagnosed according to the proposed DSM-5.
650		7	\|a Substance use disorder \|2 Elsevier
650		7	\|a DSM-IV \|2 Elsevier
650		7	\|a DSM-5 \|2 Elsevier
650		7	\|a Kappa \|2 Elsevier
650		7	\|a Concordance \|2 Elsevier
650		7	\|a Diagnosis \|2 Elsevier
700	1		\|a Dawson, Deborah A. \|4 oth
700	1		\|a Goldstein, Risë B. \|4 oth
700	1		\|a Grant, Bridget F. \|4 oth
773	0	8	\|i Enthalten in \|n Elsevier Science \|a Clark, Matthew ELSEVIER \|t Statistical analysis to identify biomarkers for safety \|d 2018 \|d an international journal on biomedical and psychosocial approaches \|g Amsterdam [u.a.] \|w (DE-627)ELV000553670
773	1	8	\|g volume:132 \|g year:2013 \|g number:1 \|g day:1 \|g month:09 \|g pages:387-390 \|g extent:4
856	4	0	\|u https://doi.org/10.1016/j.drugalcdep.2013.02.036 \|3 Volltext
912			\|a GBV_USEFLAG_U
912			\|a GBV_ELV
912			\|a SYSFLAG_U
912			\|a FID-PHARM
912			\|a SSG-OLC-PHA
912			\|a SSG-OPC-PHA
936	b	k	\|a 44.38 \|j Pharmakologie \|q VZ
936	b	k	\|a 44.39 \|j Toxikologie \|q VZ
951			\|a AR
952			\|d 132 \|j 2013 \|e 1 \|b 1 \|c 0901 \|h 387-390 \|g 4
953			\|2 045F \|a 610

Indexfelder

author_variant	w m c wm wmc
matchkey_str	comptonwilsonmdawsondeborahagoldsteinris:2013----:rswlbtensidpnecads5usacueiodrfrpod
hierarchy_sort_str	2013
bklnumber	44.38 44.39
publishDate	2013
allfields	10.1016/j.drugalcdep.2013.02.036 doi GBVA2013012000002.pica (DE-627)ELV016911024 (ELSEVIER)S0376-8716(13)00107-5 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 15,3 ssgn PHARM DE-84 fid 44.38 bkl 44.39 bkl Compton, Wilson M. verfasserin aut Crosswalk between DSM-IV dependence and DSM-5 substance use disorders for opioids, cannabis, cocaine and alcohol 2013 4 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Ascertaining agreement between DSM-IV and DSM-5 is important to determine the applicability of treatments for DSM-IV conditions to persons diagnosed according to the proposed DSM-5. Substance use disorder Elsevier DSM-IV Elsevier DSM-5 Elsevier Kappa Elsevier Concordance Elsevier Diagnosis Elsevier Dawson, Deborah A. oth Goldstein, Risë B. oth Grant, Bridget F. oth Enthalten in Elsevier Science Clark, Matthew ELSEVIER Statistical analysis to identify biomarkers for safety 2018 an international journal on biomedical and psychosocial approaches Amsterdam [u.a.] (DE-627)ELV000553670 volume:132 year:2013 number:1 day:1 month:09 pages:387-390 extent:4 https://doi.org/10.1016/j.drugalcdep.2013.02.036 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA 44.38 Pharmakologie VZ 44.39 Toxikologie VZ AR 132 2013 1 1 0901 387-390 4 045F 610
spelling	10.1016/j.drugalcdep.2013.02.036 doi GBVA2013012000002.pica (DE-627)ELV016911024 (ELSEVIER)S0376-8716(13)00107-5 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 15,3 ssgn PHARM DE-84 fid 44.38 bkl 44.39 bkl Compton, Wilson M. verfasserin aut Crosswalk between DSM-IV dependence and DSM-5 substance use disorders for opioids, cannabis, cocaine and alcohol 2013 4 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Ascertaining agreement between DSM-IV and DSM-5 is important to determine the applicability of treatments for DSM-IV conditions to persons diagnosed according to the proposed DSM-5. Substance use disorder Elsevier DSM-IV Elsevier DSM-5 Elsevier Kappa Elsevier Concordance Elsevier Diagnosis Elsevier Dawson, Deborah A. oth Goldstein, Risë B. oth Grant, Bridget F. oth Enthalten in Elsevier Science Clark, Matthew ELSEVIER Statistical analysis to identify biomarkers for safety 2018 an international journal on biomedical and psychosocial approaches Amsterdam [u.a.] (DE-627)ELV000553670 volume:132 year:2013 number:1 day:1 month:09 pages:387-390 extent:4 https://doi.org/10.1016/j.drugalcdep.2013.02.036 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA 44.38 Pharmakologie VZ 44.39 Toxikologie VZ AR 132 2013 1 1 0901 387-390 4 045F 610
allfields_unstemmed	10.1016/j.drugalcdep.2013.02.036 doi GBVA2013012000002.pica (DE-627)ELV016911024 (ELSEVIER)S0376-8716(13)00107-5 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 15,3 ssgn PHARM DE-84 fid 44.38 bkl 44.39 bkl Compton, Wilson M. verfasserin aut Crosswalk between DSM-IV dependence and DSM-5 substance use disorders for opioids, cannabis, cocaine and alcohol 2013 4 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Ascertaining agreement between DSM-IV and DSM-5 is important to determine the applicability of treatments for DSM-IV conditions to persons diagnosed according to the proposed DSM-5. Substance use disorder Elsevier DSM-IV Elsevier DSM-5 Elsevier Kappa Elsevier Concordance Elsevier Diagnosis Elsevier Dawson, Deborah A. oth Goldstein, Risë B. oth Grant, Bridget F. oth Enthalten in Elsevier Science Clark, Matthew ELSEVIER Statistical analysis to identify biomarkers for safety 2018 an international journal on biomedical and psychosocial approaches Amsterdam [u.a.] (DE-627)ELV000553670 volume:132 year:2013 number:1 day:1 month:09 pages:387-390 extent:4 https://doi.org/10.1016/j.drugalcdep.2013.02.036 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA 44.38 Pharmakologie VZ 44.39 Toxikologie VZ AR 132 2013 1 1 0901 387-390 4 045F 610
allfieldsGer	10.1016/j.drugalcdep.2013.02.036 doi GBVA2013012000002.pica (DE-627)ELV016911024 (ELSEVIER)S0376-8716(13)00107-5 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 15,3 ssgn PHARM DE-84 fid 44.38 bkl 44.39 bkl Compton, Wilson M. verfasserin aut Crosswalk between DSM-IV dependence and DSM-5 substance use disorders for opioids, cannabis, cocaine and alcohol 2013 4 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Ascertaining agreement between DSM-IV and DSM-5 is important to determine the applicability of treatments for DSM-IV conditions to persons diagnosed according to the proposed DSM-5. Substance use disorder Elsevier DSM-IV Elsevier DSM-5 Elsevier Kappa Elsevier Concordance Elsevier Diagnosis Elsevier Dawson, Deborah A. oth Goldstein, Risë B. oth Grant, Bridget F. oth Enthalten in Elsevier Science Clark, Matthew ELSEVIER Statistical analysis to identify biomarkers for safety 2018 an international journal on biomedical and psychosocial approaches Amsterdam [u.a.] (DE-627)ELV000553670 volume:132 year:2013 number:1 day:1 month:09 pages:387-390 extent:4 https://doi.org/10.1016/j.drugalcdep.2013.02.036 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA 44.38 Pharmakologie VZ 44.39 Toxikologie VZ AR 132 2013 1 1 0901 387-390 4 045F 610
allfieldsSound	10.1016/j.drugalcdep.2013.02.036 doi GBVA2013012000002.pica (DE-627)ELV016911024 (ELSEVIER)S0376-8716(13)00107-5 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 15,3 ssgn PHARM DE-84 fid 44.38 bkl 44.39 bkl Compton, Wilson M. verfasserin aut Crosswalk between DSM-IV dependence and DSM-5 substance use disorders for opioids, cannabis, cocaine and alcohol 2013 4 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Ascertaining agreement between DSM-IV and DSM-5 is important to determine the applicability of treatments for DSM-IV conditions to persons diagnosed according to the proposed DSM-5. Substance use disorder Elsevier DSM-IV Elsevier DSM-5 Elsevier Kappa Elsevier Concordance Elsevier Diagnosis Elsevier Dawson, Deborah A. oth Goldstein, Risë B. oth Grant, Bridget F. oth Enthalten in Elsevier Science Clark, Matthew ELSEVIER Statistical analysis to identify biomarkers for safety 2018 an international journal on biomedical and psychosocial approaches Amsterdam [u.a.] (DE-627)ELV000553670 volume:132 year:2013 number:1 day:1 month:09 pages:387-390 extent:4 https://doi.org/10.1016/j.drugalcdep.2013.02.036 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA 44.38 Pharmakologie VZ 44.39 Toxikologie VZ AR 132 2013 1 1 0901 387-390 4 045F 610
language	English
source	Enthalten in Statistical analysis to identify biomarkers for safety Amsterdam [u.a.] volume:132 year:2013 number:1 day:1 month:09 pages:387-390 extent:4
sourceStr	Enthalten in Statistical analysis to identify biomarkers for safety Amsterdam [u.a.] volume:132 year:2013 number:1 day:1 month:09 pages:387-390 extent:4
format_phy_str_mv	Article
bklname	Pharmakologie Toxikologie
institution	findex.gbv.de
topic_facet	Substance use disorder DSM-IV DSM-5 Kappa Concordance Diagnosis
dewey-raw	610
isfreeaccess_bool	false
container_title	Statistical analysis to identify biomarkers for safety
authorswithroles_txt_mv	Compton, Wilson M. @@aut@@ Dawson, Deborah A. @@oth@@ Goldstein, Risë B. @@oth@@ Grant, Bridget F. @@oth@@
publishDateDaySort_date	2013-01-01T00:00:00Z
hierarchy_top_id	ELV000553670
dewey-sort	3610
id	ELV016911024
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV016911024</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623132325.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180602s2013 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.drugalcdep.2013.02.036</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2013012000002.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV016911024</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0376-8716(13)00107-5</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">15,3</subfield><subfield code="2">ssgn</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">PHARM</subfield><subfield code="q">DE-84</subfield><subfield code="2">fid</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.38</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.39</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Compton, Wilson M.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Crosswalk between DSM-IV dependence and DSM-5 substance use disorders for opioids, cannabis, cocaine and alcohol</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2013</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">4</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Ascertaining agreement between DSM-IV and DSM-5 is important to determine the applicability of treatments for DSM-IV conditions to persons diagnosed according to the proposed DSM-5.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Substance use disorder</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">DSM-IV</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">DSM-5</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Kappa</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Concordance</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Diagnosis</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dawson, Deborah A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Goldstein, Risë B.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Grant, Bridget F.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Clark, Matthew ELSEVIER</subfield><subfield code="t">Statistical analysis to identify biomarkers for safety</subfield><subfield code="d">2018</subfield><subfield code="d">an international journal on biomedical and psychosocial approaches</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV000553670</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:132</subfield><subfield code="g">year:2013</subfield><subfield code="g">number:1</subfield><subfield code="g">day:1</subfield><subfield code="g">month:09</subfield><subfield code="g">pages:387-390</subfield><subfield code="g">extent:4</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.drugalcdep.2013.02.036</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-PHARM</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.38</subfield><subfield code="j">Pharmakologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.39</subfield><subfield code="j">Toxikologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">132</subfield><subfield code="j">2013</subfield><subfield code="e">1</subfield><subfield code="b">1</subfield><subfield code="c">0901</subfield><subfield code="h">387-390</subfield><subfield code="g">4</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
author	Compton, Wilson M.
spellingShingle	Compton, Wilson M. ddc 610 ssgn 15,3 fid PHARM bkl 44.38 bkl 44.39 Elsevier Substance use disorder Elsevier DSM-IV Elsevier DSM-5 Elsevier Kappa Elsevier Concordance Elsevier Diagnosis Crosswalk between DSM-IV dependence and DSM-5 substance use disorders for opioids, cannabis, cocaine and alcohol
authorStr	Compton, Wilson M.
ppnlink_with_tag_str_mv	@@773@@(DE-627)ELV000553670
format	electronic Article
dewey-ones	610 - Medicine & health
delete_txt_mv	keep
author_role	aut
collection	elsevier
remote_str	true
illustrated	Not Illustrated
topic_title	610 610 DE-600 610 VZ 15,3 ssgn PHARM DE-84 fid 44.38 bkl 44.39 bkl Crosswalk between DSM-IV dependence and DSM-5 substance use disorders for opioids, cannabis, cocaine and alcohol Substance use disorder Elsevier DSM-IV Elsevier DSM-5 Elsevier Kappa Elsevier Concordance Elsevier Diagnosis Elsevier
topic	ddc 610 ssgn 15,3 fid PHARM bkl 44.38 bkl 44.39 Elsevier Substance use disorder Elsevier DSM-IV Elsevier DSM-5 Elsevier Kappa Elsevier Concordance Elsevier Diagnosis
topic_unstemmed	ddc 610 ssgn 15,3 fid PHARM bkl 44.38 bkl 44.39 Elsevier Substance use disorder Elsevier DSM-IV Elsevier DSM-5 Elsevier Kappa Elsevier Concordance Elsevier Diagnosis
topic_browse	ddc 610 ssgn 15,3 fid PHARM bkl 44.38 bkl 44.39 Elsevier Substance use disorder Elsevier DSM-IV Elsevier DSM-5 Elsevier Kappa Elsevier Concordance Elsevier Diagnosis
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	zu
author2_variant	d a d da dad r b g rb rbg b f g bf bfg
hierarchy_parent_title	Statistical analysis to identify biomarkers for safety
hierarchy_parent_id	ELV000553670
dewey-tens	610 - Medicine & health
hierarchy_top_title	Statistical analysis to identify biomarkers for safety
isfreeaccess_txt	false
familylinks_str_mv	(DE-627)ELV000553670
title	Crosswalk between DSM-IV dependence and DSM-5 substance use disorders for opioids, cannabis, cocaine and alcohol
ctrlnum	(DE-627)ELV016911024 (ELSEVIER)S0376-8716(13)00107-5
title_full	Crosswalk between DSM-IV dependence and DSM-5 substance use disorders for opioids, cannabis, cocaine and alcohol
author_sort	Compton, Wilson M.
journal	Statistical analysis to identify biomarkers for safety
journalStr	Statistical analysis to identify biomarkers for safety
lang_code	eng
isOA_bool	false
dewey-hundreds	600 - Technology
recordtype	marc
publishDateSort	2013
contenttype_str_mv	zzz
container_start_page	387
author_browse	Compton, Wilson M.
container_volume	132
physical	4
class	610 610 DE-600 610 VZ 15,3 ssgn PHARM DE-84 fid 44.38 bkl 44.39 bkl
format_se	Elektronische Aufsätze
author-letter	Compton, Wilson M.
doi_str_mv	10.1016/j.drugalcdep.2013.02.036
dewey-full	610
title_sort	crosswalk between dsm-iv dependence and dsm-5 substance use disorders for opioids, cannabis, cocaine and alcohol
title_auth	Crosswalk between DSM-IV dependence and DSM-5 substance use disorders for opioids, cannabis, cocaine and alcohol
abstract	Ascertaining agreement between DSM-IV and DSM-5 is important to determine the applicability of treatments for DSM-IV conditions to persons diagnosed according to the proposed DSM-5.
abstractGer	Ascertaining agreement between DSM-IV and DSM-5 is important to determine the applicability of treatments for DSM-IV conditions to persons diagnosed according to the proposed DSM-5.
abstract_unstemmed	Ascertaining agreement between DSM-IV and DSM-5 is important to determine the applicability of treatments for DSM-IV conditions to persons diagnosed according to the proposed DSM-5.
collection_details	GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA
container_issue	1
title_short	Crosswalk between DSM-IV dependence and DSM-5 substance use disorders for opioids, cannabis, cocaine and alcohol
url	https://doi.org/10.1016/j.drugalcdep.2013.02.036
remote_bool	true
author2	Dawson, Deborah A. Goldstein, Risë B. Grant, Bridget F.
author2Str	Dawson, Deborah A. Goldstein, Risë B. Grant, Bridget F.
ppnlink	ELV000553670
mediatype_str_mv	z
isOA_txt	false
hochschulschrift_bool	false
author2_role	oth oth oth
doi_str	10.1016/j.drugalcdep.2013.02.036
up_date	2024-07-06T20:39:41.116Z
_version_	1803863595278139392
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV016911024</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623132325.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180602s2013 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.drugalcdep.2013.02.036</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2013012000002.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV016911024</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0376-8716(13)00107-5</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">15,3</subfield><subfield code="2">ssgn</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">PHARM</subfield><subfield code="q">DE-84</subfield><subfield code="2">fid</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.38</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.39</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Compton, Wilson M.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Crosswalk between DSM-IV dependence and DSM-5 substance use disorders for opioids, cannabis, cocaine and alcohol</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2013</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">4</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Ascertaining agreement between DSM-IV and DSM-5 is important to determine the applicability of treatments for DSM-IV conditions to persons diagnosed according to the proposed DSM-5.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Substance use disorder</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">DSM-IV</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">DSM-5</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Kappa</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Concordance</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Diagnosis</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dawson, Deborah A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Goldstein, Risë B.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Grant, Bridget F.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Clark, Matthew ELSEVIER</subfield><subfield code="t">Statistical analysis to identify biomarkers for safety</subfield><subfield code="d">2018</subfield><subfield code="d">an international journal on biomedical and psychosocial approaches</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV000553670</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:132</subfield><subfield code="g">year:2013</subfield><subfield code="g">number:1</subfield><subfield code="g">day:1</subfield><subfield code="g">month:09</subfield><subfield code="g">pages:387-390</subfield><subfield code="g">extent:4</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.drugalcdep.2013.02.036</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-PHARM</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.38</subfield><subfield code="j">Pharmakologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.39</subfield><subfield code="j">Toxikologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">132</subfield><subfield code="j">2013</subfield><subfield code="e">1</subfield><subfield code="b">1</subfield><subfield code="c">0901</subfield><subfield code="h">387-390</subfield><subfield code="g">4</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
score	7.4003468

Nicht das Richtige dabei?

Schreiben Sie uns!

Crosswalk between DSM-IV dependence and DSM-5 substance use disorders for opioids, cannabis, cocaine and alcohol

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?